RU2302240C2 - Производные карбаматов для предотвращения или лечения психотических нарушений - Google Patents

Производные карбаматов для предотвращения или лечения психотических нарушений Download PDF

Info

Publication number
RU2302240C2
RU2302240C2 RU2003128983/14A RU2003128983A RU2302240C2 RU 2302240 C2 RU2302240 C2 RU 2302240C2 RU 2003128983/14 A RU2003128983/14 A RU 2003128983/14A RU 2003128983 A RU2003128983 A RU 2003128983A RU 2302240 C2 RU2302240 C2 RU 2302240C2
Authority
RU
Russia
Prior art keywords
formula
group
disorder
enantiomer
psychotic
Prior art date
Application number
RU2003128983/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2003128983A (ru
Inventor
Карлос Р. ПЛАТА-САЛАМАН (US)
Карлос Р. Плата-Саламан
Бою ЗАО (US)
Бою ЗАО
Рой Э. ТУАЙМЭН (US)
Рой Э. ТУАЙМЭН
Original Assignee
Орто-Макнейл Фармасьютикал, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орто-Макнейл Фармасьютикал, Инк. filed Critical Орто-Макнейл Фармасьютикал, Инк.
Publication of RU2003128983A publication Critical patent/RU2003128983A/ru
Application granted granted Critical
Publication of RU2302240C2 publication Critical patent/RU2302240C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2003128983/14A 2001-02-27 2002-02-21 Производные карбаматов для предотвращения или лечения психотических нарушений RU2302240C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
US60/271,889 2001-02-27
US10/081,761 2002-02-21
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
RU2003128983A RU2003128983A (ru) 2005-03-10
RU2302240C2 true RU2302240C2 (ru) 2007-07-10

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003128983/14A RU2302240C2 (ru) 2001-02-27 2002-02-21 Производные карбаматов для предотвращения или лечения психотических нарушений

Country Status (25)

Country Link
US (1) US6541513B2 (https=)
EP (1) EP1401424B1 (https=)
JP (1) JP4276841B2 (https=)
KR (1) KR100886578B1 (https=)
CN (1) CN1262271C (https=)
AR (1) AR032876A1 (https=)
AT (1) ATE346597T1 (https=)
AU (1) AU2002242296B2 (https=)
BR (1) BR0207829A (https=)
CA (1) CA2439480C (https=)
CZ (1) CZ302412B6 (https=)
DE (1) DE60216457T2 (https=)
DK (1) DK1401424T3 (https=)
ES (1) ES2275844T3 (https=)
HU (1) HUP0303342A3 (https=)
IL (2) IL157588A0 (https=)
MX (1) MXPA03007722A (https=)
NO (1) NO20033801L (https=)
NZ (1) NZ527991A (https=)
PL (1) PL365021A1 (https=)
PT (1) PT1401424E (https=)
RS (1) RS51056B (https=)
RU (1) RU2302240C2 (https=)
TW (1) TWI251486B (https=)
WO (1) WO2002067927A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7349301A (en) * 2000-07-21 2002-02-05 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
ES2262826T3 (es) 2001-02-27 2006-12-01 Ortho-Mcneil Pharmaceutical, Inc. Uso de un compuesto de carbamato en la prevencion o el tratamiento de transtornos de ansiedad.
PL364680A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368164A1 (en) 2001-07-16 2005-03-21 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
AU2005335241B9 (en) * 2005-07-26 2012-12-20 Sk Biopharmaceuticals Co., Ltd. Methods for treating substance-related disorders
CA2667949A1 (en) * 2006-10-30 2008-05-08 Janssen Pharmaceutica N.V. Methods for treating depression
MX2009004798A (es) * 2006-10-31 2009-08-12 Janssen Pharmaceutica Nv Tratamiento de los trastornos generalizados del desarrollo.
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9566261B2 (en) 2013-03-12 2017-02-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2023712C1 (ru) * 1989-06-09 1994-11-30 Дзе Апджон Компани Трициклические азотсодержащие соединения и производные тетрагидрохинолина или их фармацевтически приемлемые соли
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2023712C1 (ru) * 1989-06-09 1994-11-30 Дзе Апджон Компани Трициклические азотсодержащие соединения и производные тетрагидрохинолина или их фармацевтически приемлемые соли
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
КАПЛАН Г. и др. Клиническая психиатрия. - М.: ГЭОТАР МЕДИЦИНА, 1994, с.124. VOVIN R.Ia. et al. Effectiveness of finlepsin in the prophylactic therapy of phasic affective psychoses. Zh Nevropatol Psikhiatr Im S S Korsakova. 1987; 87(9):1396-400. *
Психиатрия. / Под ред. Р.Шейдера. - М.: Практика, 1998, с.420. *

Also Published As

Publication number Publication date
CZ302412B6 (cs) 2011-05-04
RS67503A (sr) 2006-12-15
CA2439480A1 (en) 2002-09-06
EP1401424A1 (en) 2004-03-31
AR032876A1 (es) 2003-11-26
CN1505507A (zh) 2004-06-16
CZ20032297A3 (cs) 2004-06-16
JP4276841B2 (ja) 2009-06-10
PT1401424E (pt) 2007-02-28
ES2275844T3 (es) 2007-06-16
BR0207829A (pt) 2004-06-22
US6541513B2 (en) 2003-04-01
HUP0303342A3 (en) 2012-07-30
EP1401424B1 (en) 2006-11-29
NZ527991A (en) 2005-04-29
IL157588A0 (en) 2004-03-28
RU2003128983A (ru) 2005-03-10
RS51056B (sr) 2010-10-31
WO2002067927A1 (en) 2002-09-06
PL365021A1 (en) 2004-12-27
TWI251486B (en) 2006-03-21
NO20033801D0 (no) 2003-08-26
NO20033801L (no) 2003-10-22
KR100886578B1 (ko) 2009-03-05
IL157588A (en) 2009-12-24
CA2439480C (en) 2011-04-26
MXPA03007722A (es) 2004-11-12
DE60216457T2 (de) 2007-09-20
AU2002242296B2 (en) 2006-06-29
DK1401424T3 (da) 2007-02-26
KR20030076713A (ko) 2003-09-26
JP2004523556A (ja) 2004-08-05
CN1262271C (zh) 2006-07-05
HUP0303342A2 (hu) 2004-01-28
DE60216457D1 (de) 2007-01-11
ATE346597T1 (de) 2006-12-15
US20020165272A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
RU2302240C2 (ru) Производные карбаматов для предотвращения или лечения психотических нарушений
KR101335941B1 (ko) 수면-각성 장애의 치료
KR20120080656A (ko) 주의력 결핍/과잉행동 장애(ａｄｈｄ)의 치료 방법
JP2008542378A (ja) 精神病性障害を管理する方法および組成物
JP2010531879A (ja) 水素化ピリド［４，３−ｂ］インドールに基づく抗不安作用を示す薬物、その薬理学的な化合物および適用方法
RU2294739C2 (ru) Производные карбамата для применения для предупреждения или лечения расстройств движений
TW202327572A (zh) 用於輔助心理治療的ｒ－ｍｄｍａ和ｓ－ｍｄｍａ
US20250122164A1 (en) N,n-dimethylamphetamine analogs for treating brain disorders
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
KR20080089414A (ko) 우울증 치료를 위한 벤조-융합된 헤테로사이클 설파미드유도체의 용도
RS51790B (sr) Upotreba derivata benzo-kondenzovanih heterocikličkih sulfamida za lečenje manije i bipolarnog poremećaja
DE60210960T2 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
CN101272776B (zh) 氨基甲酸酯在制备治疗物质滥用相关疾病药物中的用途
US20060167026A1 (en) Antipsychotic molecular-targeting epithelial growth factor receptor
CA3179105A1 (en) The combination of acetyl leucine and 4-aminopyridine or acetazolamide for treating ataxia
ZA200307469B (en) Carbamate compounds for use in preventing or treating psychotic disorders.
WO2005077367A1 (en) 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-2s-phenyl-piperidin-3s-yl)-amine for the treatment of social phobia
Witkin et al. Protection Against Cocaine Toxicity in mice by the DopamineD3/D2 Agonist (+)-PD-128,907

Legal Events

Date Code Title Description
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20190207

PD4A Correction of name of patent owner
PC41 Official registration of the transfer of exclusive right

Effective date: 20190506